nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—Salicylic acid—Niacin—atherosclerosis	0.351	1	CrCrCtD
Aminosalicylic Acid—ALOX5—atherosclerosis	0.237	0.53	CbGaD
Aminosalicylic Acid—MPO—atherosclerosis	0.153	0.342	CbGaD
Aminosalicylic Acid—PTGS2—atherosclerosis	0.0572	0.128	CbGaD
Aminosalicylic Acid—MPO—superior mesenteric artery—atherosclerosis	0.0174	0.41	CbGeAlD
Aminosalicylic Acid—MPO—artery—atherosclerosis	0.00186	0.0438	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—atherosclerosis	0.00157	0.037	CbGeAlD
Aminosalicylic Acid—CHUK—connective tissue—atherosclerosis	0.00156	0.0367	CbGeAlD
Aminosalicylic Acid—PTGS2—leg—atherosclerosis	0.00154	0.0363	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—atherosclerosis	0.00145	0.0342	CbGeAlD
Aminosalicylic Acid—PTGS2—hindlimb—atherosclerosis	0.00137	0.0324	CbGeAlD
Aminosalicylic Acid—CHUK—cardiovascular system—atherosclerosis	0.00135	0.032	CbGeAlD
Aminosalicylic Acid—Hypothyroidism—Niacin—atherosclerosis	0.00128	0.0245	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Niacin—atherosclerosis	0.00123	0.0235	CcSEcCtD
Aminosalicylic Acid—CHUK—adipose tissue—atherosclerosis	0.00119	0.0282	CbGeAlD
Aminosalicylic Acid—PTGS2—appendage—atherosclerosis	0.00118	0.0278	CbGeAlD
Aminosalicylic Acid—Vasculitis—Lovastatin—atherosclerosis	0.000983	0.0188	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Ezetimibe—atherosclerosis	0.000964	0.0184	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Simvastatin—atherosclerosis	0.000919	0.0175	CcSEcCtD
Aminosalicylic Acid—PTGS1—artery—atherosclerosis	0.000882	0.0208	CbGeAlD
Aminosalicylic Acid—ALOX5—connective tissue—atherosclerosis	0.000877	0.0207	CbGeAlD
Aminosalicylic Acid—PTGS2—artery—atherosclerosis	0.000843	0.0199	CbGeAlD
Aminosalicylic Acid—CHUK—liver—atherosclerosis	0.000838	0.0198	CbGeAlD
Aminosalicylic Acid—Vasculitis—Pravastatin—atherosclerosis	0.000831	0.0159	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Lovastatin—atherosclerosis	0.000778	0.0149	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000771	0.0147	CcSEcCtD
Aminosalicylic Acid—ALOX5—cardiovascular system—atherosclerosis	0.000763	0.018	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—atherosclerosis	0.000745	0.0176	CbGeAlD
Aminosalicylic Acid—MPO—connective tissue—atherosclerosis	0.000742	0.0175	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Simvastatin—atherosclerosis	0.000728	0.0139	CcSEcCtD
Aminosalicylic Acid—Purpura—Lovastatin—atherosclerosis	0.000722	0.0138	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000721	0.0138	CcSEcCtD
Aminosalicylic Acid—PTGS2—endothelium—atherosclerosis	0.000712	0.0168	CbGeAlD
Aminosalicylic Acid—Mesalazine—ALOX5—atherosclerosis	0.000687	0.297	CrCbGaD
Aminosalicylic Acid—PTGS1—blood vessel—atherosclerosis	0.000687	0.0162	CbGeAlD
Aminosalicylic Acid—Purpura—Simvastatin—atherosclerosis	0.000676	0.0129	CcSEcCtD
Aminosalicylic Acid—ALOX5—adipose tissue—atherosclerosis	0.000673	0.0159	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Pravastatin—atherosclerosis	0.000658	0.0126	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood vessel—atherosclerosis	0.000656	0.0155	CbGeAlD
Aminosalicylic Acid—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000652	0.0124	CcSEcCtD
Aminosalicylic Acid—MPO—cardiovascular system—atherosclerosis	0.000646	0.0152	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000621	0.0118	CcSEcCtD
Aminosalicylic Acid—Jaundice—Rosuvastatin—atherosclerosis	0.000617	0.0118	CcSEcCtD
Aminosalicylic Acid—Purpura—Pravastatin—atherosclerosis	0.000611	0.0117	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000598	0.0114	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Rosuvastatin—atherosclerosis	0.000568	0.0108	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000526	0.01	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Niacin—atherosclerosis	0.00052	0.00993	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000516	0.00985	CcSEcCtD
Aminosalicylic Acid—Jaundice—Ezetimibe—atherosclerosis	0.000513	0.00979	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Pravastatin—atherosclerosis	0.000512	0.00978	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000492	0.00939	CcSEcCtD
Aminosalicylic Acid—Jaundice—Simvastatin—atherosclerosis	0.000489	0.00934	CcSEcCtD
Aminosalicylic Acid—Flatulence—Rosuvastatin—atherosclerosis	0.000488	0.00931	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Lovastatin—atherosclerosis	0.000482	0.00919	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Ezetimibe—atherosclerosis	0.000472	0.00902	CcSEcCtD
Aminosalicylic Acid—ALOX5—liver—atherosclerosis	0.000472	0.0111	CbGeAlD
Aminosalicylic Acid—Weight decreased—Pravastatin—atherosclerosis	0.00046	0.00879	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Simvastatin—atherosclerosis	0.000451	0.0086	CcSEcCtD
Aminosalicylic Acid—Jaundice—Niacin—atherosclerosis	0.000449	0.00857	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000445	0.00849	CcSEcCtD
Aminosalicylic Acid—Mesalazine—MPO—atherosclerosis	0.000443	0.192	CrCbGaD
Aminosalicylic Acid—Jaundice—Pravastatin—atherosclerosis	0.000442	0.00844	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Niacin—atherosclerosis	0.000414	0.0079	CcSEcCtD
Aminosalicylic Acid—Flatulence—Lovastatin—atherosclerosis	0.000413	0.00789	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ezetimibe—atherosclerosis	0.000411	0.00785	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Lovastatin—atherosclerosis	0.000411	0.00784	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Pravastatin—atherosclerosis	0.000407	0.00777	CcSEcCtD
Aminosalicylic Acid—Flatulence—Ezetimibe—atherosclerosis	0.000405	0.00773	CcSEcCtD
Aminosalicylic Acid—MPO—liver—atherosclerosis	0.000399	0.00942	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000396	0.00756	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000395	0.00755	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—atherosclerosis	0.000393	0.17	CrCbGaD
Aminosalicylic Acid—Flatulence—Simvastatin—atherosclerosis	0.000387	0.00738	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Simvastatin—atherosclerosis	0.000384	0.00733	CcSEcCtD
Aminosalicylic Acid—Anaemia—Ezetimibe—atherosclerosis	0.00038	0.00725	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Lovastatin—atherosclerosis	0.000375	0.00716	CcSEcCtD
Aminosalicylic Acid—Anaemia—Simvastatin—atherosclerosis	0.000363	0.00692	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Niacin—atherosclerosis	0.00036	0.00687	CcSEcCtD
Aminosalicylic Acid—Flatulence—Niacin—atherosclerosis	0.000355	0.00677	CcSEcCtD
Aminosalicylic Acid—PTGS1—connective tissue—atherosclerosis	0.000352	0.00831	CbGeAlD
Aminosalicylic Acid—Leukopenia—Simvastatin—atherosclerosis	0.000351	0.0067	CcSEcCtD
Aminosalicylic Acid—Flatulence—Pravastatin—atherosclerosis	0.000349	0.00667	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000348	0.00664	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Pravastatin—atherosclerosis	0.000347	0.00663	CcSEcCtD
Aminosalicylic Acid—PTGS2—connective tissue—atherosclerosis	0.000337	0.00794	CbGeAlD
Aminosalicylic Acid—Thrombocytopenia—Lovastatin—atherosclerosis	0.000335	0.00639	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00033	0.0063	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Ezetimibe—atherosclerosis	0.000329	0.00628	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000329	0.00627	CcSEcCtD
Aminosalicylic Acid—Anaemia—Pravastatin—atherosclerosis	0.000328	0.00625	CcSEcCtD
Aminosalicylic Acid—Anorexia—Lovastatin—atherosclerosis	0.000326	0.00623	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Ezetimibe—atherosclerosis	0.000326	0.00622	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Niacin—atherosclerosis	0.000322	0.00615	CcSEcCtD
Aminosalicylic Acid—Urticaria—Rosuvastatin—atherosclerosis	0.000321	0.00612	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Rosuvastatin—atherosclerosis	0.000319	0.00609	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Pravastatin—atherosclerosis	0.000317	0.00606	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Simvastatin—atherosclerosis	0.000313	0.00598	CcSEcCtD
Aminosalicylic Acid—PTGS1—cardiovascular system—atherosclerosis	0.000306	0.00723	CbGeAlD
Aminosalicylic Acid—Anorexia—Simvastatin—atherosclerosis	0.000305	0.00582	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000305	0.00581	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000298	0.00568	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Lovastatin—atherosclerosis	0.000298	0.00568	CcSEcCtD
Aminosalicylic Acid—PTGS2—cardiovascular system—atherosclerosis	0.000293	0.00691	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Ezetimibe—atherosclerosis	0.000292	0.00557	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00029	0.00553	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Niacin—atherosclerosis	0.000286	0.00545	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Pravastatin—atherosclerosis	0.000283	0.00541	CcSEcCtD
Aminosalicylic Acid—Anorexia—Niacin—atherosclerosis	0.00028	0.00535	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00028	0.00534	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Simvastatin—atherosclerosis	0.000278	0.00531	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000276	0.00527	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Rosuvastatin—atherosclerosis	0.000276	0.00527	CcSEcCtD
Aminosalicylic Acid—Anorexia—Pravastatin—atherosclerosis	0.000276	0.00526	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000274	0.00524	CcSEcCtD
Aminosalicylic Acid—Urticaria—Lovastatin—atherosclerosis	0.000272	0.00519	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Lovastatin—atherosclerosis	0.000271	0.00516	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lovastatin—atherosclerosis	0.000271	0.00516	CcSEcCtD
Aminosalicylic Acid—PTGS1—adipose tissue—atherosclerosis	0.00027	0.00637	CbGeAlD
Aminosalicylic Acid—Dizziness—Rosuvastatin—atherosclerosis	0.000267	0.0051	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ezetimibe—atherosclerosis	0.000267	0.00509	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ezetimibe—atherosclerosis	0.000265	0.00506	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ezetimibe—atherosclerosis	0.000265	0.00506	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000262	0.005	CcSEcCtD
Aminosalicylic Acid—PTGS2—adipose tissue—atherosclerosis	0.000258	0.00609	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Niacin—atherosclerosis	0.000256	0.00488	CcSEcCtD
Aminosalicylic Acid—Rash—Rosuvastatin—atherosclerosis	0.000255	0.00486	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Rosuvastatin—atherosclerosis	0.000254	0.00485	CcSEcCtD
Aminosalicylic Acid—Urticaria—Simvastatin—atherosclerosis	0.000254	0.00485	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Niacin—atherosclerosis	0.000254	0.00484	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Simvastatin—atherosclerosis	0.000253	0.00483	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Simvastatin—atherosclerosis	0.000253	0.00483	CcSEcCtD
Aminosalicylic Acid—Headache—Rosuvastatin—atherosclerosis	0.000253	0.00483	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Lovastatin—atherosclerosis	0.000252	0.00481	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Pravastatin—atherosclerosis	0.000252	0.0048	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ezetimibe—atherosclerosis	0.000247	0.00472	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Niacin—atherosclerosis	0.00024	0.00459	CcSEcCtD
Aminosalicylic Acid—Nausea—Rosuvastatin—atherosclerosis	0.00024	0.00458	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000237	0.00452	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Simvastatin—atherosclerosis	0.000236	0.0045	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Lovastatin—atherosclerosis	0.000234	0.00447	CcSEcCtD
Aminosalicylic Acid—Urticaria—Niacin—atherosclerosis	0.000234	0.00446	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Niacin—atherosclerosis	0.000232	0.00443	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Niacin—atherosclerosis	0.000232	0.00443	CcSEcCtD
Aminosalicylic Acid—Urticaria—Pravastatin—atherosclerosis	0.00023	0.00439	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ezetimibe—atherosclerosis	0.00023	0.00438	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Pravastatin—atherosclerosis	0.000229	0.00437	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Pravastatin—atherosclerosis	0.000229	0.00437	CcSEcCtD
Aminosalicylic Acid—Dizziness—Lovastatin—atherosclerosis	0.000226	0.00432	CcSEcCtD
Aminosalicylic Acid—Dizziness—Ezetimibe—atherosclerosis	0.000222	0.00424	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Simvastatin—atherosclerosis	0.000219	0.00418	CcSEcCtD
Aminosalicylic Acid—Vomiting—Lovastatin—atherosclerosis	0.000218	0.00415	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Niacin—atherosclerosis	0.000217	0.00413	CcSEcCtD
Aminosalicylic Acid—Rash—Lovastatin—atherosclerosis	0.000216	0.00412	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Lovastatin—atherosclerosis	0.000216	0.00411	CcSEcCtD
Aminosalicylic Acid—Headache—Lovastatin—atherosclerosis	0.000214	0.00409	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ezetimibe—atherosclerosis	0.000213	0.00407	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Pravastatin—atherosclerosis	0.000213	0.00407	CcSEcCtD
Aminosalicylic Acid—Dizziness—Simvastatin—atherosclerosis	0.000212	0.00404	CcSEcCtD
Aminosalicylic Acid—Rash—Ezetimibe—atherosclerosis	0.000212	0.00404	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—atherosclerosis	0.000211	0.0915	CrCbGaD
Aminosalicylic Acid—Dermatitis—Ezetimibe—atherosclerosis	0.000211	0.00404	CcSEcCtD
Aminosalicylic Acid—Headache—Ezetimibe—atherosclerosis	0.00021	0.00401	CcSEcCtD
Aminosalicylic Acid—Vomiting—Simvastatin—atherosclerosis	0.000204	0.00388	CcSEcCtD
Aminosalicylic Acid—Nausea—Lovastatin—atherosclerosis	0.000203	0.00388	CcSEcCtD
Aminosalicylic Acid—Rash—Simvastatin—atherosclerosis	0.000202	0.00385	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Simvastatin—atherosclerosis	0.000202	0.00385	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Niacin—atherosclerosis	0.000201	0.00384	CcSEcCtD
Aminosalicylic Acid—Headache—Simvastatin—atherosclerosis	0.000201	0.00383	CcSEcCtD
Aminosalicylic Acid—Nausea—Ezetimibe—atherosclerosis	0.000199	0.00381	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pravastatin—atherosclerosis	0.000198	0.00378	CcSEcCtD
Aminosalicylic Acid—Dizziness—Niacin—atherosclerosis	0.000194	0.00371	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pravastatin—atherosclerosis	0.000191	0.00365	CcSEcCtD
Aminosalicylic Acid—Nausea—Simvastatin—atherosclerosis	0.00019	0.00363	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—atherosclerosis	0.000188	0.0815	CrCbGaD
Aminosalicylic Acid—Vomiting—Niacin—atherosclerosis	0.000187	0.00357	CcSEcCtD
Aminosalicylic Acid—Rash—Niacin—atherosclerosis	0.000185	0.00354	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Niacin—atherosclerosis	0.000185	0.00353	CcSEcCtD
Aminosalicylic Acid—Headache—Niacin—atherosclerosis	0.000184	0.00351	CcSEcCtD
Aminosalicylic Acid—Vomiting—Pravastatin—atherosclerosis	0.000184	0.00351	CcSEcCtD
Aminosalicylic Acid—Rash—Pravastatin—atherosclerosis	0.000182	0.00348	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Pravastatin—atherosclerosis	0.000182	0.00348	CcSEcCtD
Aminosalicylic Acid—Headache—Pravastatin—atherosclerosis	0.000181	0.00346	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—atherosclerosis	0.000181	0.00427	CbGeAlD
Aminosalicylic Acid—Nausea—Niacin—atherosclerosis	0.000175	0.00333	CcSEcCtD
Aminosalicylic Acid—Nausea—Pravastatin—atherosclerosis	0.000172	0.00328	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—atherosclerosis	0.000166	0.0718	CrCbGaD
Aminosalicylic Acid—Salicylic acid—PTGS2—atherosclerosis	0.000118	0.0509	CrCbGaD
Aminosalicylic Acid—Salicylic acid—ALB—atherosclerosis	0.000105	0.0454	CrCbGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA2—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCG1—atherosclerosis	1.06e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCG5—atherosclerosis	1.04e-05	9.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.04e-05	9.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.04e-05	9.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—atherosclerosis	1.04e-05	9.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.02e-05	9.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.02e-05	9.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD14—atherosclerosis	1.01e-05	9.65e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—atherosclerosis	1.01e-05	9.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPA—atherosclerosis	1.01e-05	9.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR2—atherosclerosis	1.01e-05	9.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOA2—atherosclerosis	1e-05	9.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—atherosclerosis	1e-05	9.51e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARA—atherosclerosis	9.95e-06	9.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FABP4—atherosclerosis	9.92e-06	9.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LCAT—atherosclerosis	9.92e-06	9.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—VCAM1—atherosclerosis	9.79e-06	9.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BGN—atherosclerosis	9.76e-06	9.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA4—atherosclerosis	9.74e-06	9.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.69e-06	9.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA5—atherosclerosis	9.66e-06	9.19e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AGT—atherosclerosis	9.64e-06	9.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	9.59e-06	9.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP7A1—atherosclerosis	9.57e-06	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	9.57e-06	9.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SOCS3—atherosclerosis	9.5e-06	9.04e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—atherosclerosis	9.44e-06	8.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	9.43e-06	8.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.38e-06	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAV1—atherosclerosis	9.36e-06	8.9e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOA1—atherosclerosis	9.34e-06	8.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G1B—atherosclerosis	9.3e-06	8.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BGN—atherosclerosis	9.25e-06	8.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.19e-06	8.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.12e-06	8.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.11e-06	8.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.09e-06	8.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALOX5—atherosclerosis	8.98e-06	8.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VWF—atherosclerosis	8.97e-06	8.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	8.92e-06	8.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOC3—atherosclerosis	8.92e-06	8.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LDLR—atherosclerosis	8.86e-06	8.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP27A1—atherosclerosis	8.85e-06	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	8.71e-06	8.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	8.66e-06	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—atherosclerosis	8.66e-06	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3—atherosclerosis	8.65e-06	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—atherosclerosis	8.63e-06	8.21e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CG—atherosclerosis	8.52e-06	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	8.5e-06	8.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA2—atherosclerosis	8.39e-06	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G2A—atherosclerosis	8.39e-06	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALOX5AP—atherosclerosis	8.39e-06	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALOX15—atherosclerosis	8.39e-06	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AGER—atherosclerosis	8.32e-06	7.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—atherosclerosis	8.3e-06	7.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.3e-06	7.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCF1—atherosclerosis	8.29e-06	7.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCG5—atherosclerosis	8.28e-06	7.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.27e-06	7.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCG—atherosclerosis	8.23e-06	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—atherosclerosis	8.23e-06	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOB—atherosclerosis	8.19e-06	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—atherosclerosis	8.11e-06	7.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.09e-06	7.69e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—INS—atherosclerosis	8.07e-06	7.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CST3—atherosclerosis	8.06e-06	7.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NAMPT—atherosclerosis	8.06e-06	7.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD36—atherosclerosis	8.04e-06	7.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.01e-06	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LIPC—atherosclerosis	8.01e-06	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPA—atherosclerosis	8e-06	7.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—atherosclerosis	7.98e-06	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOC3—atherosclerosis	7.96e-06	7.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LDLR—atherosclerosis	7.91e-06	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR2—atherosclerosis	7.83e-06	7.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDNRA—atherosclerosis	7.83e-06	7.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LPL—atherosclerosis	7.82e-06	7.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CYBA—atherosclerosis	7.79e-06	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BGN—atherosclerosis	7.75e-06	7.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CETP—atherosclerosis	7.72e-06	7.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.69e-06	7.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA5—atherosclerosis	7.67e-06	7.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NAMPT—atherosclerosis	7.64e-06	7.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GHRL—atherosclerosis	7.63e-06	7.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PARP1—atherosclerosis	7.63e-06	7.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLAT—atherosclerosis	7.63e-06	7.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRKCG—atherosclerosis	7.6e-06	7.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOC3—atherosclerosis	7.54e-06	7.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LDLR—atherosclerosis	7.5e-06	7.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.45e-06	7.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFB—atherosclerosis	7.42e-06	7.06e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—atherosclerosis	7.4e-06	7.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SCARB1—atherosclerosis	7.4e-06	7.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G1B—atherosclerosis	7.38e-06	7.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—atherosclerosis	7.36e-06	7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.3e-06	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—atherosclerosis	7.25e-06	6.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—atherosclerosis	7.25e-06	6.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSPA1B—atherosclerosis	7.24e-06	6.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.23e-06	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.22e-06	6.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.2e-06	6.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALOX5—atherosclerosis	7.13e-06	6.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK8—atherosclerosis	7.12e-06	6.78e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—atherosclerosis	7.07e-06	6.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—atherosclerosis	7.04e-06	6.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCF1—atherosclerosis	7.01e-06	6.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMGCR—atherosclerosis	6.98e-06	6.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—atherosclerosis	6.96e-06	6.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—atherosclerosis	6.95e-06	6.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFB—atherosclerosis	6.85e-06	6.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KNG1—atherosclerosis	6.7e-06	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—atherosclerosis	6.67e-06	6.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGTR1—atherosclerosis	6.66e-06	6.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CYBA—atherosclerosis	6.59e-06	6.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.59e-06	6.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—atherosclerosis	6.55e-06	6.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CAV1—atherosclerosis	6.49e-06	6.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLG—atherosclerosis	6.49e-06	6.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOA1—atherosclerosis	6.48e-06	6.16e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—atherosclerosis	6.47e-06	6.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PARP1—atherosclerosis	6.45e-06	6.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAMPT—atherosclerosis	6.4e-06	6.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.36e-06	6.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LIPC—atherosclerosis	6.35e-06	6.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOC3—atherosclerosis	6.32e-06	6.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.3e-06	6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LDLR—atherosclerosis	6.28e-06	5.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCA1—atherosclerosis	6.23e-06	5.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK3—atherosclerosis	6.22e-06	5.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS3—atherosclerosis	6.14e-06	5.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CETP—atherosclerosis	6.13e-06	5.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—atherosclerosis	6.11e-06	5.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.02e-06	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP3—atherosclerosis	5.93e-06	5.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—atherosclerosis	5.91e-06	5.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SCARB1—atherosclerosis	5.87e-06	5.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOB—atherosclerosis	5.73e-06	5.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.72e-06	5.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—atherosclerosis	5.64e-06	5.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—atherosclerosis	5.6e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—atherosclerosis	5.6e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMGCR—atherosclerosis	5.54e-06	5.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LPL—atherosclerosis	5.47e-06	5.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—atherosclerosis	5.34e-06	5.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCG—atherosclerosis	5.32e-06	5.07e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—atherosclerosis	5.18e-06	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—atherosclerosis	5.14e-06	4.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOB—atherosclerosis	5.12e-06	4.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—atherosclerosis	5.07e-06	4.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—atherosclerosis	4.98e-06	4.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCA1—atherosclerosis	4.94e-06	4.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—atherosclerosis	4.91e-06	4.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPL—atherosclerosis	4.89e-06	4.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOB—atherosclerosis	4.85e-06	4.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFB—atherosclerosis	4.8e-06	4.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—atherosclerosis	4.77e-06	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—atherosclerosis	4.68e-06	4.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD36—atherosclerosis	4.64e-06	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LPL—atherosclerosis	4.63e-06	4.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—atherosclerosis	4.59e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—atherosclerosis	4.59e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—atherosclerosis	4.55e-06	4.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—atherosclerosis	4.55e-06	4.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOA1—atherosclerosis	4.54e-06	4.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—atherosclerosis	4.52e-06	4.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCG—atherosclerosis	4.5e-06	4.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—atherosclerosis	4.49e-06	4.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—atherosclerosis	4.4e-06	4.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—atherosclerosis	4.38e-06	4.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—atherosclerosis	4.33e-06	4.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARA—atherosclerosis	4.32e-06	4.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—atherosclerosis	4.24e-06	4.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—atherosclerosis	4.22e-06	4.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—atherosclerosis	4.2e-06	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—atherosclerosis	4.18e-06	3.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—atherosclerosis	4.17e-06	3.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—atherosclerosis	4.15e-06	3.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—atherosclerosis	4.14e-06	3.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—atherosclerosis	4.09e-06	3.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOB—atherosclerosis	4.06e-06	3.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFB—atherosclerosis	4.06e-06	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—atherosclerosis	4.06e-06	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA1—atherosclerosis	4.05e-06	3.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—atherosclerosis	4.03e-06	3.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—atherosclerosis	3.95e-06	3.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—atherosclerosis	3.92e-06	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—atherosclerosis	3.88e-06	3.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPL—atherosclerosis	3.88e-06	3.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—atherosclerosis	3.86e-06	3.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—atherosclerosis	3.85e-06	3.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOA1—atherosclerosis	3.84e-06	3.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—atherosclerosis	3.79e-06	3.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—atherosclerosis	3.79e-06	3.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—atherosclerosis	3.78e-06	3.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—atherosclerosis	3.7e-06	3.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD36—atherosclerosis	3.68e-06	3.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—atherosclerosis	3.62e-06	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—atherosclerosis	3.62e-06	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—atherosclerosis	3.6e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—atherosclerosis	3.57e-06	3.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—atherosclerosis	3.5e-06	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—atherosclerosis	3.5e-06	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—atherosclerosis	3.49e-06	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—atherosclerosis	3.44e-06	3.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARA—atherosclerosis	3.43e-06	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—atherosclerosis	3.35e-06	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—atherosclerosis	3.32e-06	3.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—atherosclerosis	3.32e-06	3.16e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—atherosclerosis	3.25e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—atherosclerosis	3.25e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—atherosclerosis	3.25e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—atherosclerosis	3.22e-06	3.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA1—atherosclerosis	3.21e-06	3.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—atherosclerosis	3.21e-06	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—atherosclerosis	3.07e-06	2.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—atherosclerosis	3.05e-06	2.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—atherosclerosis	3.05e-06	2.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—atherosclerosis	2.93e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—atherosclerosis	2.91e-06	2.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—atherosclerosis	2.83e-06	2.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—atherosclerosis	2.81e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—atherosclerosis	2.78e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—atherosclerosis	2.76e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—atherosclerosis	2.73e-06	2.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—atherosclerosis	2.68e-06	2.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—atherosclerosis	2.65e-06	2.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—atherosclerosis	2.55e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—atherosclerosis	2.48e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—atherosclerosis	2.45e-06	2.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—atherosclerosis	2.45e-06	2.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—atherosclerosis	2.44e-06	2.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—atherosclerosis	2.44e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—atherosclerosis	2.34e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—atherosclerosis	2.27e-06	2.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—atherosclerosis	2.26e-06	2.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—atherosclerosis	2.07e-06	1.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—atherosclerosis	1.98e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—atherosclerosis	1.92e-06	1.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—atherosclerosis	1.71e-06	1.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—atherosclerosis	1.58e-06	1.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—atherosclerosis	1.45e-06	1.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—atherosclerosis	1.41e-06	1.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—atherosclerosis	1.34e-06	1.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—atherosclerosis	1.12e-06	1.07e-05	CbGpPWpGaD
